Priority-driven Collaborative Cancer Research Scheme (PdCCRS)

Cancer Australia

The Priority-driven Collaborative Cancer Research Scheme (PdCCRS) is Cancer Australia's innovative annual national research project grants funding scheme which brings together government and other funders to collaboratively fund cancer research in identified priority areas in Australia. Cancer Australia and its Funding partners have dedicated research priorities General Cancers and Childhood Cancers of Survival.

Key Dates 

Wednesday 6 March 2019 Applications open in RGMS to Cancer Australia' PdCCRS
Wednesday 10 April 2019, 5pm (AEST) *Minimum Data Deadline - CIAs must commence an application and complete the RGMS minimum data requirements by 5pm.Applications that do not meet these requirements will not be accepted by the NHMRC or by Cancer Australia
Wednesday 10 April 2019

Internal Deadline for PdCCRS application forms due to GMO - Details of your Compliance Advisor will be advised shortly after the internal deadline.

Tuesday 7 May 2019, 9am Final Application to GMO - Completed compliance reviewed application due to the GMO for submission.
Wednesday 8 May 2019, 5pm (AEST) NHMRC Deadline - No application will be accepted by the NHMRC after 5pm under any circumstance.
Wednesday 15 May 2019, 5pm (AEST) PdCCRS Deadline - Corresponding completed PdCCRS Questions application form due to Cancer Australia - PdCCRS Application form are submitted to Cancer Australia by the GMO 
August - September 2019 Two phase assessment of applications
December 2019 Notification to successful and unsuccessful applicants
January 2020 Negotiation and award of grant agreements
1 February 2020 Earliest date for start of grant activity
30 June 2020 Latest date for start of grant activity

 *Applications that do not meet the minimum data deadline will not be accepted by the NHMRC or by Cancer Australia

PdCCRS 2019 Resource Page Contents

  1. Contacts and Support 
  2. Eligibility 
  3. Priorities and Funding Partners
  4. Funding Categories
  5. How to Apply
  6. Research Grants Management System (RGMS)

Contacts and Support 

Strategic Advice (Research Strategy Office | RSO)

The RSO is available for strategic advice on the scope, nature and suitability of any proposed project, how to address the selection criteria including track record, and general grantsmanship advice. Researchers are encouraged to discuss their project with the RSO at the early stages of their application process as fundamental issues are difficult to resolve late in the process. Please send any component of your proposal quoting your application ID for strategic advice, as a Word file, to MedicalGrants.RSO@unsw.edu.au

Compliance & Eligibility Advice (Research Grants and Contracts, Grants Management Office | GMO)

You will be advised on the details of your individual Compliance Advisor shortly after the internal deadline Wednesday 10 April 2019. In the meantime, you can contact your Grants Officer or the GMO on mygrants.gmo@unsw.edu.au when your application is ready to be reviewed for compliance, by completing the following steps

  1. Send an email to your Grants Officer  or  mygrants.gmo@unsw.edu.au to advise you are ready for a compliance review and attach a word version of your corresponding PdCCRS Questions application form, ensure that NHMRC application ID number and the CIA’s surname are inserted into the header field on each page of the PdCCRS Questions document i.e. 1191234_JONES.
Eligibility

2019 PdCCRS Grant Guidelines - Standard and Early Career Research Grants

  • Applications are invited from appropriately qualified researchers and must be submitted via the nominated NHMRC approved Administering Institution.
  • The proposed research must directly align with at least one research priority area specified by Cancer Australia or its Funding Partners.
  • Applicants named as Chief Investigator A can only submit a maximum of two applications to the 2020 round of the PdCCRS. Applications to the PdCCRS will not contribute to the NHMRC capping limits provided that the NHMRC application indicates it is requesting funding only from Cancer Australia and its Funding Partners.
  • Applicants must submit a grant application to NHMRC through RGMS in addition to submission of a completed PdCCRS Questions form to Cancer Australia.
  • Experienced investigators as well as Early Career Researchers with less than 7 years post-PhD or post-MBBS are eligible to apply.

Standard PdCCRS 

Applications must submitted through the NHMRC Ideas Grants or Clinical Trials and Cohort Studies grants schemes and must satisfy all the requirements set out in the NHMRC Grant Guidelines as published on GrantConnect in addition to satisfying the requirements as set out in the 2020 PdCCRS Grant Guidelines.
 

Early Career Researcher (7 years post-PhD or post-MBBS) 

PdCCRS applications must submitted through the NHMRC Ideas Grants scheme and must satisfy all the requirements set out in the NHMRC Ideas Grant Guidelines as published on GrantConnect in addition to satisfying the requirements as set out in the 2020 PdCCRS Grant Guidelines.
At the close of applications, applicants applying for Early Career Researcher Project Grants must be: less than 3 years post-PhD or post-MBBS for Category B grants; more than 3 years but less than 7 years post-PhD or post-MBBS for Category C grants; and must be less than 7 years post-PhD or post-MBBS for Category D grants. You will need to indicate which funding category, B, C or D you are apply to and you will need to provide the date of the letter advising you that your PhD or equivalent was approved.

0
Funding Priorities and Funding Partners

Priority – General Cancer Research 

Funding Partners and their priorities 

Cancer Australia (Category A, B, C D)

Cancer Australia’s framework of general research priorities relate to specific areas of cancer research, tumour types and populations with poorer outcomes. In looking to support research in these areas, Cancer Australia encourages research which focuses on emerging issues, innovation and novel approaches in;

  • Translational research
  • Tumor Types
  • Populations with poor and unwarranted variations in cancer outcomes

Cancer Australia: gynaecological cancers (Category A)

Cancer Australia: lung cancer (Category A) 

Cure Cancer Australia (Category B, C, D) 

  1. General Priorities (Categories B and C applicants only): 
  2. Bioinformatics for cancer research (Category D applicants only) 

Leukaemia Foundation of Australia (Category C) 
The Leukaemia Foundation of Australia invites applications geared towards supporting research into amyloidosis or haematological malignancies in the following priority areas: 

  • Understanding the biology of haematological malignancies 
  • Accelerating the adoption of personalised medicine 
  • New diagnostics 
  • Novel therapies 
  • Epidemiology and prevention research 

National Breast Cancer Foundation (Category A) 

  1. New/optimised treatments for Triple negative breast cancer, comprising new target discovery, new delivery methods, new drugs, new therapeutic regimes etc. 
  2. New/optimised treatments for metastatic/locally advanced breast cancer comprising new target discovery, new delivery methods, new drugs, new therapeutic regimes etc. 
  3. Health services delivery, comprising big data linkage, epidemiological research to address disparities and variances in outcomes, translation of evidence into policy and practice, quality of healthcare etc. 

The Kids’ Cancer Project (Category A, C) 

  1. Adolescents and young adults (AYAs) 
  2. Improving survival and treatments

Priority – Childhood Cancers of Low Survival

Cancer Australia (Category A, B, C, D)
Cancer Australia’s research priorities in childhood cancers of low survival address the following cancer types and research focus areas:     

  • Localised and advanced disease for any of the following cancers of low survival in children (0-14 years)* 
  • Molecular drivers of childhood cancer (Common Scientific Outline categories of Biology and Aetiology) 
  • Novel approaches to diagnosis and treatment (Common Scientific Outline categories of Early Detection, Diagnosis, and Prognosis, and Treatment)

Australian Lions Childhood Cancer Research Foundation (Category C)
ALCCRF is dedicated to increasing the survival rates of childhood cancer, the foundation will fund research research investigating high risk, low survival childhood cancers. Applications with a focus on brain cancer, neuroblastoma, or sarcoma, will be considered.

The Leukemia Foundation (Category C)
The Leukaemia Foundation of Australia invites applications geared towards supporting paediatric haematological malignancy research in the following priority areas in childhood cancers of low survival: 

  • Understanding the biology of haematological malignancies 
  • Accelerating the adoption of personalised medicine 
  • New diagnostics 
  • Novel therapies 
  • Epidemiology and prevention research

My Room (Category C)
My Room will fund clinical or translational research focusing on paediatric cancers of all types in children and adolescents up to 18 years. 
Projects that investigate clinical applications of treatments or technologies to enhance prevention, diagnosis, and therapies for paediatric cancers will be considered. 

The Kids Cancer Project (Category A, C)
The Kids’ Cancer Project defines a child as an individual up to the age of 18 years old. Research will be funded under the following priority: 

  • Improving survival and treatments 
0
Funding Categories

The PdCCRS supports funding for two main types of research grants: 

  • Standard Project Grants (Category A) 
  • Early Career Researcher Project Grants (Category B, C, & D)
  • Standard Project Grants - Category A 

Grants are available for a duration of one to three years. The budget in any single year may range from $10,000 to approximately $200,000 (GST exclusive) and the total grant value cannot exceed $200,000/year i.e. $600,000 for a three-year grant. 

  • Early Career Researcher Project Grants – Categories B, C and D 

You will need to indicate which funding category, B, C or D you are applying to and provide the date when your PhD or equivalent was approved.
Category B 
Grants are available for one year duration with maximum funding of $100,000 (GST exclusive) to support post-doctoral researchers with less than 3 years post-doctoral experience, or less than 3 years’ experience after graduation from medical school, at the closing date for applications. 
Category C 
Grants are available for up to two years duration with maximum funding of $200,000 (GST exclusive), with a maximum in any one year of $100,000 (GST exclusive), to support post-doctoral researchers with greater than 3 years and less than 7 years post-doctoral experience, or greater than 3 years and less than 7 years post-doctoral experience after graduation from medical school, at the closing date for applications. 
Category D 
Grants in the field of bioinformatics research are available for one year duration with maximum funding of $100,000 (GST exclusive), to support post-doctoral researchers with less than 7 years post-doctoral experience, or less than 7 years after graduation from medical school, at the closing date for applications. 

0
How to apply

Complete the PdCCRS Questions forms and submit to the GMO by Wednesday 10 April 2019.

2019 PdCCRS Question_Instructions to Applicants 

PdCCRS applications will only be accepted if an application has been submitted to NHMRC’s Ideas Grants or Clinical Trials and Cohort Studies Grants schemes and a corresponding PdCCRS Questions application form has been submitted to Cancer Australia.

The PdCCRS is aligned with the NHMRC Ideas Grants and Clinical Trials and Cohort Studies Grants schemes.

Four different project grant opportunities are available in the PdCCRS and separate PdCCRS Questions application forms are available for: 

Standard PdCCRS applications can be submitted through the NHMRC Ideas Grants or Clinical Trials and Cohort Studies grants schemes and must satisfy all the requirements set out in the NHMRC Grant Guidelines as published on GrantConnect in addition to satisfying the requirements as set out in the 2019 PdCCRS Grant Guidelines.
Early Career Researcher PdCCRS applications can be submitted through the NHMRC Ideas Grants scheme and must satisfy all the requirements set out in the NHMRC Ideas Grant Guidelines as published on GrantConnect in addition to satisfying the requirements as set out in the 2019 PdCCRS Grant Guidelines.

  • PdCCRS applications will only be accepted if an application has been submitted to NHMRC’s Ideas Grants or Clinical Trials and Cohort Studies Grants schemes and a corresponding PdCCRS Questions application form has been submitted to Cancer Australia
  • In RGMS you must select the ‘Cancer Australia and its Funding Partners’ box in order for your application to be considered for funding by Cancer Australia. Follow the NHMRC guidelines to submit your project proposal and ensure that the minimum amount of data has been entered by  5pm AEST Wednesday 8 May 2019.

 

0
Research Grants Management System (RGMS)

RGMS is a web-based system used to prepare and submit research applications and assessments for all NHMRC Grants. 

RGMS is a program and portfolio management system that enables you to apply for, track and administer NHMRC grants online, as well as participate in peer review. Researchers can also maintain a profile and curriculum vitae, which is used for application and other administrative purposes.

RGMS Support

  • New RGMS accounts can be requested by accessing the RGMS login page. Select the ’New to RGMS? Submit a new user request here' link and follow the prompts on-screen.
  • Access the NHMRC RGMS Access instructions and Resources Support Page for training tutorials, offline forms and other helpful appendices and NHMRC Information page
  • The NHMRC Character Counting Tool can assist with checking your various sections are within the limits prior pasting into the RGMS fields within your application. There are several sections of your Ideas Grant proposals where a character limit is enforced. The NHMRC Character Counting Tool can assist with checking that sections of your proposal adhere to these limits prior to inserting text into the RGMS field. This is particularly useful because many conventional programs (e.g MS Word, Adobe PDF) use a different character counting method to RGMS.

Research Administration Organisation (RAO) Edit Access

What is RAO Edit Access?

As you commence your application in RGMS, you will be given the option to grant Research Administration Office (RAO) Edit Access. This allows your Compliance Advisor at the Grants Management Office to generate new snapshots of your application for compliance review whenever required. 

How do I grant RAO Edit Access?

It is recommended you grant access at the time you commence your application. After you select ‘University of New South Wales’ as the Administering Institution, select ‘yes’ for RAO Edit Access.

Can I grant edit access to other members of my project team?

No. The lead investigator (CIA) is responsible for creating, requesting snapshots and submitting an application, including certification. Other members of the research team can only views the application and latest snapshots, but cannot edit it.

0